Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lusher

Showing results (61-70 of 177) with videos related to

Pageof 18
Sort By:
The American Journal of Medicine|October 1, 1978
Severe factor VIII and factor IX deficiency in femalesJ M Lusher, C W McMillan
Seminars in Hematology|April 1, 1990
Viral safety and inhibitor development associated with factor VIIIC ultra-purified from plasma in hemophiliacs previously unexposed to factor VIIIC concentrates. The Monoclate Study GroupJ M Lusher, P M Salzman
Advances in Experimental Medicine and Biology|January 1, 1972
Evaluation of oral urea in the management of sickle cell anemiaJ M Lusher, M I Barnhart
Transfusion|May 1, 1993
Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices CommitteeC K Kasper, J M Lusher
American Journal of Hematology|January 1, 1976
Festschrift in homor of Wolf W. Zuelzer, M.DJ M Lusher, A K Brown
American Journal of Hematology|January 1, 1976
The human spleen as revealed by scanning electron microscopyM I Barnhart, J M Lusher
American Journal of Diseases of Children (1960)|March 1, 1977
Childhood idiopathic thrombocytopenic purpuraW W Zuelzer, J M Lusher
The American Journal of Pediatric Hematology/Oncology|January 1, 1982
Neurological complications of sickle cell anemiaS A Sarnaik, J M Lusher
The Journal of Pediatrics|February 1, 1983
DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand diseaseA I Warrier, J M Lusher
American Journal of Hematology|December 1, 1986
Intravenous gammaglobulin (Gaminume) for treatment of chronic idiopathic thrombocytopenic purpura (ITP): a two-year follow-upI A Warrier, J M Lusher
Pageof 18

Showing results (61-70 of 177) with videos related to

Sort By:
Pageof 18
The American Journal of Medicine|October 1, 1978
Severe factor VIII and factor IX deficiency in femalesJ M Lusher, C W McMillan
Seminars in Hematology|April 1, 1990
Viral safety and inhibitor development associated with factor VIIIC ultra-purified from plasma in hemophiliacs previously unexposed to factor VIIIC concentrates. The Monoclate Study GroupJ M Lusher, P M Salzman
Advances in Experimental Medicine and Biology|January 1, 1972
Evaluation of oral urea in the management of sickle cell anemiaJ M Lusher, M I Barnhart
Transfusion|May 1, 1993
Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices CommitteeC K Kasper, J M Lusher
American Journal of Hematology|January 1, 1976
Festschrift in homor of Wolf W. Zuelzer, M.DJ M Lusher, A K Brown
American Journal of Hematology|January 1, 1976
The human spleen as revealed by scanning electron microscopyM I Barnhart, J M Lusher
American Journal of Diseases of Children (1960)|March 1, 1977
Childhood idiopathic thrombocytopenic purpuraW W Zuelzer, J M Lusher
The American Journal of Pediatric Hematology/Oncology|January 1, 1982
Neurological complications of sickle cell anemiaS A Sarnaik, J M Lusher
The Journal of Pediatrics|February 1, 1983
DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand diseaseA I Warrier, J M Lusher
American Journal of Hematology|December 1, 1986
Intravenous gammaglobulin (Gaminume) for treatment of chronic idiopathic thrombocytopenic purpura (ITP): a two-year follow-upI A Warrier, J M Lusher
Pageof 18